Hofstetten, Switzerland

Christoph Imboden


 

 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Christoph Imboden: Innovator in Pharmaceutical Sciences

Introduction

Christoph Imboden is a notable inventor based in Hofstetten, Switzerland. With a total of three patents to his name, he has made significant contributions to the field of pharmaceutical sciences. His innovative work primarily focuses on enhancing vascular function and immunomodulation through novel compounds.

Latest Patents

Imboden's latest patents showcase his expertise in creating new pharmaceutical compositions. One notable invention is the crystalline forms of (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[Z]ylidene]-2-([Z]-propylimino)-3-o-tolyl-thiazolidin-4-one. This invention outlines the processes for the preparation of these crystalline forms, along with their potential use as agents that improve vascular function and serve as immunomodulating compounds, either individually or in conjunction with other therapies.

Another significant patent involves a process for preparing an enantiomeric trisubstituted 3,4-dihydro-isoquinoline derivative. This process includes the hydrogenation of a specific compound using a unique catalyst, namely bis[chloro-1,5-cyclooctadiene-iridium] combined with (S)-i-dicyclohexylphosphino-2-[(S)-α-(dimethylamino)-2-(dicyclohexylphosphino)benzyl]-ferrocene.

Career Highlights

Christoph Imboden has been instrumental in advancing pharmaceutical research through his role at Actelion Pharmaceuticals Ltd. His innovative mindset and dedication to research have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, Imboden has collaborated with esteemed colleagues, including Doris Domin and Matthias Helms. These partnerships have fostered an environment that encourages creativity and drives scientific progress, further enhancing his contributions to the field.

Conclusion

Christoph Imboden's work exemplifies the spirit of innovation in pharmaceutical sciences. His patents not only reflect his expertise but also hold the potential to improve human health significantly. As he continues his research and collaboration within Actelion Pharmaceuticals, the impact of his inventions will likely resonate in the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…